What's new

Human medicines European public assessment report (EPAR): Revinty Ellipta, fluticasone furoate,vilanterol, Date of authorisation: 02/05/2014, Revision: 24, Status: Authorised

Human medicines European public assessment report (EPAR): Revinty Ellipta, fluticasone furoate,vilanterol, Date of authorisation: 02/05/2014, Revision: 24, Status: Authorised

Feb 24, 2025 - 14:27
 0
Human medicines European public assessment report (EPAR): Revinty Ellipta, fluticasone furoate,vilanterol, Date of authorisation: 02/05/2014, Revision: 24, Status: Authorised
Human medicines European public assessment report (EPAR): Revinty Ellipta, fluticasone furoate,vilanterol, Date of authorisation: 02/05/2014, Revision: 24, Status: Authorised
Read More

Tags:

Previous Article

Here's why Trump tariffs may raise your car insurance premiums

Next Article

How PVCase Yield 3D modelling can increase PV bankability

Related Posts

Human medicines European public assessment report (EPAR): Xiliarx, vildagliptin, Date of authorisation: 19/11/2008, Revision: 24, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 9, 2025  0

Human medicines European public assessment report (EPAR): Mounjaro, tirzepatide, Date of authorisation: 15/09/2022, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 28, 2025  0

Substances considered as not falling within the scope o...

Feb 21, 2025  0